Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa withdrawal study in symptomatic neurogenic orthostatic hypotension
2007-005673-60Phase 3Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of droxidopa in Neurogenic Orthostatic Hypotension (nOH), sponsored by Chelsea Therapeutics International, Ltd.. Started Mar 2008; status: completed.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on 2007-005673-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005673-60.